Compare · IQV vs VEEV
IQV vs VEEV
Side-by-side comparison of IQVIA Holdings Inc. (IQV) and Veeva Systems Inc. (VEEV): market cap, price performance, sector, and recent activity on the wire.
Summary
- IQV operates in Health Care, while VEEV operates in Technology - the two are in different parts of the market.
- IQV is the larger of the two at $42.70B, about 1.1x VEEV ($40.27B).
- VEEV has been more active in the news (7 items in the past 4 weeks vs 6 for IQV).
- Both have 25 recent analyst ratings on file.
- Company
- IQVIA Holdings Inc.
- Veeva Systems Inc.
- Price
- -
- -
- Market cap
- $42.70B
- $40.27B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Biotechnology: Commercial Physical & Biological Resarch
- Computer Software: Prepackaged Software
- Exchange
- NYSE
- NYSE
- IPO
- 2013
- 2013
- News (4w)
- 6
- 7
- Recent ratings
- 25
- 25
IQVIA Holdings Inc.
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
Veeva Systems Inc.
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva Andi, Veeva OpenData, Veeva Link, Veeva Network Customer Master, Veeva Crossix, Veeva Data Cloud, and MyVeeva for Doctors; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including sales and marketing, and medical content and communications, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
Latest IQV
- IQVIA's AI-Enabled Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year
- IQVIA Ranked No. 1 Pharmaceutical Technology Provider by Everest Group
- Officer Staub W Richard sold $1,279,740 worth of shares (5,500 units at $232.68), decreasing direct ownership by 29% to 13,312 units (SEC Form 4)
- Officer Patel Bhavik sold $436,426 worth of shares (1,855 units at $235.27), decreasing direct ownership by 58% to 1,348 units (SEC Form 4)
- IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery
- SEC Form 144 filed by IQVIA Holdings Inc.
- Officer Sherbet Eric sold $1,245,800 worth of shares (5,000 units at $249.16), decreasing direct ownership by 19% to 20,999 units (SEC Form 4)
- Officer Cherofsky Keriann sold $136,827 worth of shares (558 units at $245.21), decreasing direct ownership by 16% to 2,989 units (SEC Form 4)
- Officer Bousbib Ari exercised 156,206 shares at a strike of $78.21, sold $26,092,072 worth of shares (106,279 units at $245.51) and returned $12,217,110 worth of shares to the company (49,927 units at $244.70) (SEC Form 4)
- SEC Form 144 filed by IQVIA Holdings Inc.
Latest VEEV
- Veeva Vault CRM Selected by Biogen
- Veeva Vault CRM Selected by Regeneron
- Piper Sandler resumed coverage on Veeva Systems with a new price target
- Veeva Systems Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Pres. & Chief Customer Officer Schwenger Thomas D. sold $9,008,390 worth of shares (36,000 units at $250.23) as part of a pre-agreed trading plan and exercised 35,000 shares at a strike of $154.00, decreasing direct ownership by 5% to 19,449 units (SEC Form 4)
- Veeva Vault CRM Selected by Eli Lilly and Company
- Veeva to Release Fiscal 2027 Second Quarter Results on August 26, 2026
- Guggenheim initiated coverage on Veeva Systems with a new price target
- Pres. & Chief Customer Officer Schwenger Thomas D. sold $1,000,000 worth of shares (5,000 units at $200.00) as part of a pre-agreed trading plan, decreasing direct ownership by 20% to 20,449 units (SEC Form 4)
- President & Chief of Staff Zuppas Eleni Nitsa converted options into 2,180 shares, increasing direct ownership by 7% to 33,418 units (SEC Form 4)